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Abstract
Introduction: Chronic pain in late adolescence and young adults is understudied and poorly characterized.
Objectives: We sought to characterize key variables that may impact pain interference in late adolescents and young adults with
chronic pain, including prescription opioid use, marijuana use, psychological symptoms, and obesity.
Methods: Retrospective, cross-sectional medical chart review for patients aged 17 to 23 years (N 5 283; 61% Females) seeking
care at a tertiary care pain clinic. Data on pain characteristics, health behaviors, and mental health distress were examined, in
addition to self-reported pain intensity and interference.
Results:Overlapping pain conditionswere common in this young adult sample (mean$ 2 pain conditions). Back pain was themost
commonly cited pain condition, and the majority of pain was of unknown etiology. Results revealed high rates for current opioid
prescription, overweight or obese status, andmental health problems. Those using prescription opioids weremore likely to endorse
tobacco use and had greater pain interference. Importantly, the presence ofmental health distress and opioid usewere predictive of
higher levels of pain-related interference.
Conclusion: Treatment-seeking adolescents and young adults with chronic pain evidence complex care needs that include pain
and mental comorbidities, as well as risky health behaviors. Pain and mental health distress were associated with poorer physical
health, opioid prescription and marijuana use, and pain-related interference. Findings underscore the need for additional research
on pain, treatment patterns, and health behaviors and their impact on developmental trajectories, aswell as the need to develop and
apply effective early interventions in this at-risk population.
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1. Introduction
Chronic pain is associated with substantial biopsychosocial
burdens, including impediments in daily functioning, and di-
minished participation in meaningful life pursuits. Late adoles-
cence and young adulthood may be a time of particular
vulnerability for individuals with chronic pain. The impacts of
pain-related interference may extend beyond daily difficulties in
functioning and serve to impede progress through the de-
velopmental stages of late adolescent, early adulthood, and
transition to independence. Indeed, young adulthood is a critical
developmental stage in which personal, professional, and health
trajectories are formed and solidified.23,27,43 Concomitantly, self-
regulatory skills for cognition, emotion, behavior, and stress
responses remain immature, thereby rendering many in this age
group ill-equipped to handle the stresses and consequences of
chronic pain within the context of other developmental chal-
lenges.21 Consequently, individuals with chronic pain in this age
group may be at risk of mental health distress and of maladaptive
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behaviors—such as smoking or marijuana use. Indeed, the
interplay of biopsychosocial factors and their impact on chronic
pain are expected to be particularly strong in young individuals.21
However, only a handful of studies have examined key
biobehavioral factors and health behaviors among young adults
with chronic pain,17,18,35,36 despite this being a critical de-
velopmental period to potentially mitigate the development and
progression of pain and health problems, and to reduce
treatment patterns that may have major long-term health
consequences, such as prescription opioids.
Data regarding long-term use of opioids among youth and
young adults are limited, with studies citing 21% of commercially
insured youth with back pain, neck pain, headache, or joint pain
having received an opioid prescription,35 and patients with
chronic pain and anxiety/depressive conditions or substance
abuse are 2 to 3 timesmore likely to use and remain on opioids.40
The likelihood to be prescribed opioids and use them long term
has been shown to be higher for males.35,36 Psychological
comorbidity places young adults at higher risk of opioid misuse
and worse outcomes, including negatives beliefs, catastrophiz-
ing, and greater perceived disability.37 Given the onset of
depression and substance use peaks during the adolescent
and young adult period,29 understanding how mental health
conditions are associated with opioid prescription might allow for
targeted interventions designed to mitigate long-term opioids to
treat chronic pain.
The concerns raised above are particularly salient given the
striking prevalence of chronic pain in youth and young adults.
Indeed, as many as 20% to 50% of postpubertal adolescents
report persistent pain.15,16,22,42 Among young adults, prevalence
estimates for any pain in the previous 6 months are 66.9%,
whereas chronic and disabling pain conservatively range
between 4% and 14%.3,4,25 Disabling pain in young adults
requires further study as chronic pain, and its impact on functional
status remains poorly characterized. Studies have primarily
focused on examining quality of life in this population and found
reductions in quality of life to be associated with number of pain
sites31,32 and pain intensity.20 Although the literature remains
relatively sparse, a handful of studies on older adolescents have
shown increased functional disability among those with over-
lapping musculoskeletal pain conditions compared with a single
pain type.24,30
Finally, in regards to additional key health behaviors that may
impact pain interference in young adults, research has demon-
strated negative impacts of cigarette smoking,18 alcohol use,
poor sleep quality and quantity,17 and obesity10 in chronic pain;
however, research on their association with pain interference
remains limited. Elucidating the interplay of physical and mental
health factors that specifically associate with pain-related in-
terference in adolescents and young adults could inform the
development of appropriate therapeutic interventions that could
minimize secondary impacts on developmental trajectories.
This study sought to fill an important gap in the literature and
aimed to: (1) describe key biopsychosocial factors and health
behaviors among young adults with chronic pain, which include
opioid prescription status, marijuana use, weight and obesity
status, and psychiatric symptoms (depression and anxiety); and
(2) describe the interplay between these variables and pain
interference in a sample of young adults. We hypothesized that
the current sample will have high rates of opioid use, obesity and
overweight status, and psychiatric symptoms. We also hypoth-
esize that the presence of psychiatric symptoms, sleep distur-




Retrospective, cross-sectional chart review of the electronic
medical record (EMR).
2.2. Participants
The study sample comprised 283 patients aged 17 to 23 years
seeking care at a tertiary care pain clinic between 2007 and 2011.
All datawere extracted fromEMRs, including demographics, pain
and clinical characteristics, opioid prescription status, and
substance use behavior (eg, smoking and marijuana use). In
addition, pain intensity and pain interference ratings were
retrieved from patient self-report, collected at the initial clinic
visit. Inclusion criteria for the study consisted of being between
the ages of 17 and 23 years, and the presence of a chronic pain
condition ($3 months). The study was approved by the Oregon
Health & Science University Institutional Review Board.
2.3. Measures
Data pertaining to each of the measures were extracted from the
EMRs.
2.3.1. Demographic information
Demographic information included participant sex, age, and
ethnicity at the date of clinic visit.
2.3.2. Body mass index
Body mass index (BMI) scores were calculated from height and
weight measurements using the Adult and Child (for participants
younger than 18 years) BMI calculators published by the Centers
for Disease Control and Preventions.33 A binary obesity status
variable (yes/no) was created based on BMI scores, where yes5
BMI $30.
2.3.3. Substance use
Substance use included tobacco and marijuana use, and was
extracted from the EMR. All patients at the medical center are
routinely asked about tobacco use in a Health History form.
Information about marijuana use was taken from the initial clinic
intake questionnaire and the physician’s intake note. Both were
coded as yes/no for the presence or absence of use.
2.3.4. Prescribed medications
Prescribed medications were extracted from the list of active/
current medications in the EMR and included the following
categories of medications: opioids, anticonvulsants, muscle
relaxants, antidepressants, antianxiety/mood stabilizers, sleep
aids, and anti-inflammatory medications.
2.3.5. Clinical characteristics
The presence of psychiatric symptoms was recorded by
physicians as a binary variable (yes/no) for the presence of
depressive and anxiety symptoms, and included in the Problem
List in the EMR. Furthermore, depression and anxiety were
combined to create a single mental health distress variable
indicating the presence of one or more of these symptoms. In
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addition, sleep disturbance was based on the presence of
physician noted sleep disturbance under the Problem List or
Diagnoses in the EMR. This information was also extracted
through chart reviews.
2.3.6. Pain characteristics
Pain characteristics included primary pain locations, number of
pain locations, pain duration, and pain etiology. The majority of
these characteristics were obtained through patient report on the
Brief Pain Inventory (BPI)-Short Form,8 which was completed as
part of the clinic intake.
2.3.6.1. Primary pain locations
Primary pain locations were assessed through the body map
included in theBPI andwere coded into the following regions: face,
head, shoulder/neck, chest, arm/hand, abdomen, spine, low back
pain, other back pain, leg/knee, hip, pelvic area, and other.
2.3.6.2. Number of pain locations
A number of pain locations were coded from the number of
endorsed body regions.
2.3.6.3. Pain duration
Pain duration was assessed by asking patients how long they have
experienced ongoing pain in their specified location for (in months
or years). This was reported on the clinic intake questionnaire.
2.3.6.4. Pain etiology
Pain etiology was assessed by chart review of the pain
physician’s initial evaluation note and was coded as injury-
related, surgery-related, or unknown.
2.3.6.5. Pain intensity and pain interference
Pain intensity and pain interference were assessed with the short
formof theBPI,8 whichwas administered as part of the clinic intake
questionnaire during patients’ initial visit. Pain intensity was rated
from 0 (no pain) to 10 (pain as bad as you can imagine) for current
pain, as well as worst, least, and average pain during the past
week. The 7 pain interference items include domains related to
general activity, mood, walking ability, normal work, relations with
other people, sleep, and enjoyment of life. Items were rated from
0 (no interference) to 10 (interferes completely) and were internally
consistent in this sample (a 5 0.85); the items were averaged to
yield a single pain interference score. The BPI is one of the most
widely used pain measures and has excellent psychometric data,
includinggood reliability and awealth of validity data demonstrating
that the subscales correlate as expected with other measures of
pain and functioning.8,41 This information was available for n5 182
of the sample, as noted in Table 1.
2.4. Statistical analyses
Data were analyzed using SPSS version 21. Descriptive statistics
were calculated for demographic variables and pain character-
istics. The independent samples t test was conducted to
determine sex differences on continuous study variables, namely
pain characteristics (Table 1), and x2 analyses were used for
categorical variables (eg, substance use and medication use).
Chi-square analyses were also used to describe key study
variables (mental and physical health variables) stratified by opioid
use (yes/no) (Table 2). Finally, multivariate hierarchical regression
analyses were conducted to examine the association of biopsy-
chosocial factors (ie, sleep disturbance, obesity, and mental
health distress) and opioid prescription status with pain in-
terference among patients who completed the BPI (n 5 182).
3. Results
3.1. Sample characteristics
Sample demographics and clinical characteristics are shown in
Table 1. In total, 283 patients (females5 173; 61%), with a mean
age of 20.28 years (SD 5 1.75), were included in the study
sample. On average, patients reported having at least 2 pain
locations (M5 2.21, SD5 1.75), with an average pain duration of
4.15 years (SD5 4.04, range5 0.08–20.75). Back pain was the
most commonly cited pain condition (n 5 170, 60.1%), and the
majority of pain was of unknown etiology (n 5 167, 57%). The
Table 1
Demographics and pain characteristics.
Characteristic Total (N 5 283) Females (n 5 173) Males (n 5 110) P
Age (17–23 y) 20.29 (1.73) 20.16 (1.77) 20.49 (1.65) 0.11
Number of pain locations 2.21 (1.75) 2.36 (2.03) 1.93 (1.03) 0.02
Pain duration in years 4.16 (4.28) 4.38 (4.53) 3.80 (3.87) 0.32
Pain etiology
Unknown 167 (59.0%) 110 (63.6%) 57 (51.8%) 0.08
Primary pain location
Back 170 (60.1%) 96 (55.5%) 74 (67.3%)
Head and neck 17 (6.0%) 13 (7.5%) 4 (3.6%)
Chest and arms 40 (14.1%) 26 (15.0%) 14 (12.7%)
Abdomen and pelvic area 22 (7.8%) 15 (8.7%) 7 (6.4%)
Leg 34 (12.0%) 23 (13.3%) 11 (10.0%)
BPI*
Average 6.37 (1.64) 6.35 (1.38) 6.38 (1.78) 0.89
Best 4.70 (2.22) 4.97 (2.22) 4.24 (2.17) 0.03
Worst 8.28 (1.50) 8.26 (1.58) 8.31 (1.37) 0.81
Interference 6.47 (1.97) 6.40 (2.05) 6.60 (1.85) 0.35
* Brief Pain Inventory: n 5 182; n 5 68 males and n 5 114 females.
BPI, Brief Pain Inventory.
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majority of the sample was of non-Hispanic ethnicity (n 5 270;
95%), followed by Hispanic ethnicity (n 5 9; 3.2%) and other
ethnicities combined (n 5 3; 1.2%). No information about racial
background was available.
3.2. Pain intensity and pain interference
Pain intensity and pain interference scores were available for 182
patients. Average pain intensity was 6.37 (SD 5 1.64) (range 5
4.7–8.28), and mean pain interference score was 6.47 (SD 5
1.97) ranging from 0.43 to 10. Females had a higher least pain
score (M5 4.97, SD5 2.22) than males (M5 4.24, SD5 2.17) (t
(180) 5 22.176, P 5 0.02) and reported more pain locations (t
(296) 5 22.39, P , 0.05); there were no other significant sex
differences (Table 1).
3.3. Biopsychosocial factors
The average BMI was 25.42 (SD5 7.13); 20.8% of patients were
in the overweight category and 18.5% in the obese category.
More than half of the sample was in the normal weight category
(56.6%), and a minority of patients were underweight (4.2%).
More than half of the sample (55.4%) had one or more psychiatric
symptoms documented in the medical record problem list.
Mental health distress was documented in a notable portion of
the sample; 45% (n5 127) of whom had depression and 41% (n
5 117) had anxiety. In addition, 55% (n5 157) of the sample had
documented sleep disturbance.
3.4. Smoking and marijuana use
Almost one-third of the sample (31.5%) reported smoking
a substance (N 5 94). Specifically, close to a fifth of the sample
smoked tobacco (n 5 61, 21.6%) or used marijuana (n 5
57, 20.5%).
3.5. Opioid prescription
About half of the patients had a current opioid prescription (n 5
140; 50%). Notably, among young adults who were prescribed
opioids (Table 2), tobacco smoking (x2(1)5 3.89, P5 0.04) and
pain interference (t (192) 5 22.07, P 5 0.04) were significantly
higher compared with those who were not prescribed opioids.
However, individuals with an opioid prescription did not differ
significantly than those without an opioid prescription on their
obesity/overweight status or marijuana use.
3.6. Other medications
Other frequently prescribed medications included anti-
inflammatory (n 5 87, 30.7%) and antidepressant (n 5 72,
25.4%) agents. The remainingmedications, including antianxiety/
mood stabilizers, anticonvulsants, muscle relaxants, and sleep
aids, were prescribed to less than 25% of the sample. Complete
medication use data can be found in Table 3.
3.7. Sex differences
Sex analyses for male (n5 110) and female (n5 173) participants
revealed a number of differences (Tables 1 and 4). On average,
females reported more pain locations (t (296)522.39, P, 0.05)
and tended to endorse more pain conditions with unknown
etiology (t (296) 5 1.71, P 5 0.08). Importantly, in terms of
medication prescriptions, more females were prescribed anti-
convulsants; x2 (1)5 6.161, P5 0.013, and antidepressants; x2
(1) 5 3.826, P 5 0.050, respectively. Males were more likely to
endorse marijuana use; x2(1) 5 12.13, P , 0.001, and smoking
tobacco; x2(1) 5 4.07, P 5 0.03. No sex differences were noted
for BMI. Finally, females were more likely to have documented
anxiety than males; x2 (1)5 6.95, P5 0.008, and no sex/gender
differences were noted for depression or sleep disturbance.
3.8. Regression analyses
Table 5 displays the results of a multivariate hierarchical
regression analysis. Mental health distress, defined as the
Table 2
Sample characteristics stratified by opioid use.
Characteristic Nonopioid users, (n 5 142); n (%) Opioid users, (n 5 140); n (%) x2/t P
Mental health
Depression 62 (43.4%) 65 (46.4%) 0.270 0.60
Anxiety 61 (43.0%) 56 (40.0%) 0.254 0.61
Sleep disturbance 73 (51.4%) 84 (60.0%) 2.11 0.15
Smoking
Tobacco 24 (16.8%) 37 (24.4%) 3.89 0.04
Marijuana 26 (18.6%) 31 (22.5%) 0.646 0.42
Physical health, M (SD)
BMI 25.55 (8.33) 25.28 (5.71) 0.307 0.76
Pain interference 6.12 (1.98) 6.73 (1.93) 22.07 0.04
BMI, body mass index.
Table 3












Muscle relaxant 58 (20.5)
Antidepressant 72 (25.4)
Antianxiety/mood stabilizers 31 (11.0)
Sleep aids 21 (7.4)
Anti-inflammatory 87 (30.7)
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presence of anxiety and/or depressive symptoms, uniquely
contributed to observed variance in pain interference scores,
after controlling for pain intensity (first step of model), with obesity
status, opioid prescription status, and sleep disturbance (second
step), accounting for 29.6% of the variance. The presence of
a mental health distress variable was entered in the third step of
the model, and was significantly and positively associated with
pain interference, contributing uniquely to 2.4% of the variance
above and beyond the effects of pain intensity, obesity status,
opioid prescription status, and sleep disturbance.
4. Discussion
This study describes important pain and clinical characteristics in
a sample of treatment-seeking young adults with chronic pain. A
number of key variableswere associatedwith poorer physical and
mental health, which in turn was shown to facilitate pain-related
interference.
In summary, overlapping pain conditions were common in this
sample, and back pain was the most commonly cited pain
condition, comprising 60.1% of the sample’s primary pain
location, with the majority of pain being of unknown etiology.
On average, young adults in this sample reportedmoderate levels
of pain interference and average pain intensity scores that are
higher than those reported among general community-based
young adults.28 Notably, a large portion of our sample—about
39.3%—was overweight or obese, and the 20.8% obesity rate is
significantly higher than the reported 14.5% obesity rate of
community young adults (18–24 years) in Oregon.34 Obesity was
not associated with pain interference in this sample, contrary to
previous research findings.26
Regarding substance use in this sample, tobacco and
marijuana usage was comparable with reported rates among
young adults in Oregon.7 In the study sample, males reported
greater tobacco and marijuana use than females, and marijuana
use was the only health behavior variable examined in this study
that predicted pain-related interference. Given that the direction-
ality of effects cannot be determined with cross-sectional data, it
is plausible that marijuana use may contribute to pain-related
interference, or higher levels of interference may prompt young
adults to use marijuana, for pain management or general coping.
Importantly, this study was conducted before the legalization of
marijuana in Oregon. It is unknown whether patients were using
medical marijuana with amedical marijuana card, or whether they
were using the substance illicitly. Research confirms that young
adults, especially males, may be using tobacco or marijuana as
a means of coping with or reducing pain18 and pain-related
anxiety.11,12
Depression and anxiety were common in our sample. More
females had physician-reported anxiety and used medications,
namely antidepressants and anticonvulsants. These findings are
consistent with research documenting higher rates of anxiety
among women in general, despite findings showing that anxiety
and pain sensitivity are more strongly associated for men than
women.13 Importantly, the presence of mental health distress
emerged as a unique predictor of pain interference above and
beyond the effects of pain intensity and opioid prescription status,
which supports previous research findings.1,6 This finding is
consistent with the gate control theory, which posits that with
depression and anxiety comes changes in motivational–affective
processes (eg, decreased interest and involvement in daily ac-
tivities, and increased sadness) and cognitive–evaluative pro-
cesses (eg, irrational and maladaptive thoughts, and overly
negative appraisals of coping abilities) that can affect the pro-
cessing and perception of noxious input. Furthermore, research
proposes several mechanisms that underlie pain and psycho-
logical distress, including pain catastrophizing,5 perceived help-
lessness,38 and low self-efficacy.2 Findings highlight the
importance of identifying risk factors that predict or contribute to
pain interference, as the impacts of pain-related interference may
extend beyond daily difficulties in functioning and serve to hinder
progress through the developmental stages of late adolescent,
early adulthood, and transition to independence.
Patients in our sample were prescribed a variety of different
medications. One of the most surprising results was the high rate
of opioid prescriptions. As themost frequently prescribed class of
medications, about 50% of our sample was prescribed opioids.
This was higher than reported opioid use in another young adult
sample, which found a rate of 27.4% in a large national Medicaid
sample.35 Importantly, pain interference was significantly higher
among young adults who were prescribed opioids; a crucial
finding in light of overprescribing trends and negative health
effects of long-term opioid use.9 It is possible that young adults
Table 4
Sex differences in study variables.
Characteristic Total, N (%) Male, (n 5 110); n (%) Female, (n 5 173); n (%) t/x2 P
Obesity
BMI, mean (SD) 26.56 (56) 24.74 (4.49) 22.33 0.035
Mental health
Depression 127 (44.9%) 47 (42.7%) 80 (46.2%) 0.336 0.562
Anxiety 117 (41.5%) 35 (31.8%) 82 (47.7%) 6.949 0.008
Sleep disturbance 157 (55.7%) 56 (50.9%) 101 (58.7%) 1.659 0.198
Smoking
Tobacco 61 (21.6%) 31 (28.2%) 30 (17.3%) 4.674 0.031
Marijuana 57 (20.5%) 36 (33.3%) 21 (12.4%) 17.84 0.000
BMI, body mass index.
Table 5
Multivariate hierarchical regression: predictors of pain
interference.
Δ R2 b entry b at final step
Step 1 0.265***
Average pain intensity 0.61*** 0.57***
Step 2 0.031*
Obesity status 0.13 0.14
Sleep disturbance 0.12* 0.08
Opioid use 0.12* 0.14*
Step 3 0.024**
Mental health distress 0.17*
*P , 0.05, **P , 0.01, and ***P , 0.001.
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seen in tertiary pain clinic settings may be a unique subgroup of
individuals with chronic pain in this age range, in terms of the
severity of their pain condition, which might contribute to clinical
decisions tomanage painwith opioids. However, the high rates of
prescribed opioids and its association with pain interference
reinforce the need for more research and targeted early
intervention specific to young adults. In addition, young adults
who were prescribed opioids were more likely to report tobacco
smoking, a finding that aligns with the adult literature.19 Our study
contributes to a body of evidence suggesting that opioid
prescriptions for young adults appear to be on the rise.14
Previous work has shown that young adults seeking pain relief
use pharmacological treatments despite their concerns about the
adverse effects and risk of addiction,39 thereby underscoring the
need for improved nonpharmacologic interventions. The current
study also highlights the need to address overall health in these
older adolescents/young adults, whowill face lifelong effects from
overweight and obese weight status and tobacco use, in addition
to potential negative outcomes from prescription opioids.
As a retrospective chart review, this study has a number of
limitations. Our relatively small sample is from one multidisciplin-
ary pain clinic at an academic medical center and may not be
generalizable to young adults with chronic pain in the community.
We did not have a comparison group (eg, middle-aged adults),
thus some findings may not be unique to young adults. In
addition, comprehensive information about physical and mental
health statuses was not always available in the medical record,
and our measure of mental health distress is relatively weak.
Despite the salience of alcohol use in this population, we did not
have available data on alcohol use, and future work should
include alcohol use in describing substance use in this
population. Finally, the binary nature of some study variables
may have masked their impact on pain interference in the
regression model. Future work might incorporate more in-depth
and comprehensive assessments of health and psychological
functioning in young adults.
Our study is one of the few studies that characterizes chronic
pain in late adolescence and early adulthood, and describes
associated variables, including opioid prescription, marijuana
use, obesity, mental health distress, and associations with pain
interference. Findings from this study are notable and inform
a growing body of literature, as the impacts of pain-related
interference among young adults may extend beyond daily
difficulties in functioning and serve to impede progress through
the developmental stages of late adolescent, early adulthood,
and transition to independence. Hence, variables that contrib-
ute to pain interference can become important therapeutic
targets for young adults with chronic pain, particularly in regards
to reducing psychological risks, such as depression and
anxiety, and prescription opioids. Clinical interventions such
as pain-cognitive behavioral therapy (pain-CBT) focus on
teaching pain-coping skills in addition to coping with pain-
related anxiety and depression. Pain-CBT can serve as a key
prevention approach among adolescents and young adults with
chronic pain who present with psychological risk factors.
Overall, findings highlight the importance of further examining
the effect of pain on developmental trajectories and identifica-
tion of early interventions.
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